Study of Safety and Efficacy of a Probiotic and Postbiotic in Overweight Individuals (NCT05428137) | Clinical Trial Compass
UnknownNot Applicable
Study of Safety and Efficacy of a Probiotic and Postbiotic in Overweight Individuals
South Korea180 participantsStarted 2022-07-01
Plain-language summary
Investigate the effect of a probiotic (live bacteria) and postbiotic (heat-treated bacteria) strains in overweight individuals.
Who can participate
Age range19 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Body mass index 25-33kg/m2
* Abdominal obesity (female waist circumference\>85cm; male waist circumference\>90cm)
* written informed consent
Exclusion Criteria:
* Taking the following medication within 1 month before starting the study: appetite stimulants/suppressants, lipid lowering drug, contraceptive
* taking antibiotics within 2 months before starting the study
* secondary obesity or secondary hypertension, diabetes type 1, GI disease, dyslipidaemia, type 2diabetes, hypertension
* consumption of pre- and probiotic-enriched products or dietary supplement for at least 4 weeks prior to the first screening visit
* nicotine, drug or alcohol abuse,
* other condition that, in the opinion of the investigators, would make participation not in the best interest of the patient or could prevent, limit or confound the Study's results